Meniscus-Targeted Injections for Chronic Knee Pain Due to Meniscal Tears or Degenerative Fraying: A Retrospective Study.


Journal

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
ISSN: 1550-9613
Titre abrégé: J Ultrasound Med
Pays: England
ID NLM: 8211547

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 12 10 2018
revised: 19 01 2019
accepted: 11 02 2019
pubmed: 20 3 2019
medline: 24 3 2020
entrez: 20 3 2019
Statut: ppublish

Résumé

Meniscal tears caused by acute trauma or degenerative fraying affect a wide array of individuals. An effective, long-lasting treatment has widely been sought after. Intra-articular corticosteroid injections have been among the methods of controlling pain for more than 60 years. However, such injections tend to produce short-lasting results, with profound effects lasting an average of up to 4 weeks. The purpose of this study was to determine the average duration and magnitude of pain relief after meniscal-targeted injections. The electronic medical records of 135 patients were accessed for this retrospective chart review. Patients who had meniscal tears or degenerative fraying and were treated with meniscal-targeted injections were selected. Patients' visual analog scale (VAS) pain scores (before and after treatment) were recorded, along with the percentage of pain relief and duration of pain relief. Ultrasound-guided meniscus-targeted corticosteroid injections for meniscal tears or degenerative fraying produced 5.68 (SD, 5.28) weeks of pain relief on average, with a decrease in pain from initial to follow-up visits of 2.14 (P < .0001) as per the visual analog scale score, and an Integral of Pain Relief score of 3.98. Our findings indicate a substantial benefit from 20- or 40-mg meniscus-targeted triamcinolone injections, granted the limitations of chart review research and no control group comparison. Results highlight the need for future prospective research comparing meniscus-targeted injections with intra-articular injections to identify a better modality for treating patients with chronic knee pain caused by meniscal tears or degenerative fraying.

Identifiants

pubmed: 30887572
doi: 10.1002/jum.14987
doi:

Substances chimiques

Adrenal Cortex Hormones 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2853-2859

Informations de copyright

© 2019 by the American Institute of Ultrasound in Medicine.

Références

Messner K, Gao J. The menisci of the knee joint: anatomical and functional characteristics, and a rationale for clinical treatment. J Anat 1998; 193:161-178.
Greis PE, Bardana DD, Holmstrom MC, Burks RT. Meniscal Injury, I: basic science and evaluation. J Am Acad Orthop Surg 2002; 10:168-176.
Hollander JL, Brown EM Jr, Jessar RA, Brown CY. Hydrocortisone and cortisone injected into arthritic joints: comparative effects of and use of hydrocortisone as a local anti-arthritic agent. J Am Med Assoc 1951; 147:1629-1635.
Habib G, Saliba W, Nashashibi M. Local effects of intra-articular corticosteroids. Clin Rheumatol 2010; 29:347-356.
Evans CH, Kraus VB, Setton LA. Progress in intra-articular therapy. Nat Rev Rheumatol 2014; 10:11-22.
Larsen C, Østergaard J, Larsen SW, et al. Intra-articular depot formulation principles: role in the management of postoperative pain and arthritic disorders. J Pharm Sci 2008; 97:4622-4654.
Armstrong RD, English J, Gibson T, Chakraborty JMV. Serum methylprednisolone levels following intra-articular injection of methylprednisolone acetate. Ann Rheum Dis 1981; 40:571-574.
Derendorf H, Mollmann H, Gruner A, Haack D, Gyselby G. Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administration. Clin Pharm Ther 1986; 39:313-317.
Davilla-Parilla A, Santaella-Sante B, Otero-Lopez A. Does injection site matter? A randomized controlled trial to evaluate different entry site efficacy of knee intra-articular injections. Bol Assoc Med Puerto Rico 2015; 107:78-81.
Maricar N, Parkes MJ, Callaghan MJ, Felson DT, O'Neill TW. A systematic review of where and how to inject in the knee [abstract]? Osteoarthritis Cartilage 2013; 21(suppl):S300.
Folman Y, Shabat S. Local treatment of a painful knee with corticosteroids: the efficacy of intra-articular injection compared with peri-articular soft tissue infiltration. J Musculoskelet Pain 2011; 19:154-157.
Di Sante L, Venditto T, Ioppolo F, Paoloni M, Mangone M, Alviti F. Ultrasound guided injection of a painful knee osteoarthritis with medial meniscus extrusion: a case series study. Muscles Ligaments Tendons J 2017; 7:331-337.
Xing D, Wang B, Zhang W, et al. Intra-articular platelet-rich plasma injections for knee osteoarthritis: an overview of systematic reviews and risk of bias considerations. Int J Rheum Dis 2017; 20:1612-1630.
Rezasoltani Z, Taheri M, Mofrad MK, Mohajerani S. Periarticular dextrose prolotherapy instead of intra-articular injection for pain and functional improvement in knee osteoarthritis. J Pain Res 2017; 10:1179-1187.
González-Fernández M, Ghosh N, Ellison T, McLeod JC, Pelletier CA, Williams K. Moving beyond the limitations of the visual analog scale for measuring pain: novel use of the general labeled magnitude scale in a clinical setting. Am J Phys Med Rehabil 2014; 93:75-81.
Younger J, McCue R, Mackey S. Pain outcomes: a brief review of instruments and techniques. Curr Pain Headache Rep 2009; 13:39-43.
Wang WY, Chu CM, Sung CS, et al. Using a new measurement to evaluate pain relief among cancer inpatients with clinically significant pain based on a nursing information system: a three-year hospital-based study. Pain Med 2016; 17:2067-2075.
Wilderman I, Berkovich R. Integral of pain relief as an innovative method of pain measurement. J Pain Relief 2017; 6:277.

Auteurs

Igor Wilderman (I)

Wilderman Medical Clinic, Thornhill, Ontario, Canada.

Rachel Berkovich (R)

Wilderman Medical Clinic, Thornhill, Ontario, Canada.

Christopher Meaney (C)

University of Toronto, Toronto, Ontario, Canada.

Omer Kleiner (O)

Wilderman Medical Clinic, Thornhill, Ontario, Canada.

Vsevolod Perelman (V)

Wilderman Medical Clinic, Thornhill, Ontario, Canada.
University of Toronto, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH